The company voluntarily ordered the Class 1 recall, meaning the products could pose an imminent hazard to health in patients, on Sept. 14.
Synthes said it took action after receiving six reports of patients suffering moderate to severe symptoms 6-15 months after implantation.
Read the release on Synthes’ recall of Synex II Central Body components.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 18–20 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
